Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
-
11981
-
11982
-
11983
-
11984
-
11985
-
11986
-
11987
-
11988
-
11989
-
11990
-
11991
Quantitative Western blot analysis of potential Dube3a targets Eps15 and ATPα.
Published 2013“…Also, a decrease in ATPα can be seen on this particular blot in <i>Dube3a<sup>15b</sup></i> mutants as compare to <i>w<sup>1118</sup>. …”
-
11992
-
11993
-
11994
<i>chb-3</i> encodes a novel protein with a zf-MYND motif.
Published 2010“…Y50C1, Y2F4 (<i>C. elegans</i> genomic YAC clone), and a Y48G1A.3 PCR fragment (6.5 kb) which contained the Y48G1A.3 predicted gene and 1 kb of upstream sequence, rescued the Daf-c phenotype of <i>chb-3(eg52)</i>. …”
-
11995
Purification and Characterization of the Fe<sup>II</sup>- and α-Ketoglutarate-Dependent Xanthine Hydroxylase from <i>Aspergillus nidulans</i><sup>†</sup>
Published 2007“…The αKG cosubstrate can be substituted with α-ketoadipate (9-fold decrease in <i>k</i><sub>cat</sub> and 5-fold increase in the <i>K</i><sub>m</sub> compared to those of the normal α-keto acid), while the αKG analogue <i>N</i>-oxalylglycine is a competitive inhibitor (<i>K</i><sub>i</sub> = 0.12 μM). …”
-
11996
Therapeutic efficacy of Clrn1 re-expression in Müller glia depends on expression level.
Published 2025“…Error bars=SD. Scale Bar = 50 µm. n=8-12 larvae for each genotype per condition.…”
-
11997
-
11998
-
11999
Table 1_Efficacy of encapsulated fecal microbiota transplantation and FMT via rectal enema for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial (CAP-E...
Published 2025“…Primary endpoint was clinical response defined by ≥50-point decrease in IBS-symptom severity score (IBS-SSS) at 4 weeks. …”
-
12000